Paper41756757
The Src inhibitor peptide TAT-Cx43266-283 improves survival in an intracranial murine model of lung cancer brain metastasis.
Cerveró-García P and 19 others. Neurooncol Adv, 2026. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Src inhibitor peptide TAT-Cx43266-283 improves survival in an intracranial murine model of lung cancer brain metastasis. Papers, record 41756757. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41756757
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Src inhibitor peptide TAT-Cx43266-283 improves survival in an intracranial murine model of lung cancer brain metastasis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26,669,454 | Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype. | Nat Commun | 2015 | https://conductscience.org/library/papers/26669454 | PubMed |
| 2 | 28,712,848 | A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK. | Stem Cell Reports | 2017 | https://conductscience.org/library/papers/28712848 | PubMed |
| 3 | 31,780,762 | Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases. | Sci Rep | 2019 | https://conductscience.org/library/papers/31780762 | PubMed |
| 4 | 23,009,336 | EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. | Mol Cancer | 2012 | https://conductscience.org/library/papers/23009336 | PubMed |
| 5 | 12,884,910 | Src family kinases in tumor progression and metastasis. | Cancer Metastasis Rev | 2003 | https://conductscience.org/library/papers/12884910 | PubMed |
| 6 | 33,238,452 | Connexin43 Region 266-283, via Src Inhibition, Reduces Neural Progenitor Cell Proliferation Promoted by EGF and FGF-2 and Increases Astrocytic Differentiation. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33238452 | PubMed |
| 7 | 34,503,072 | Impairment of Autophagic Flux Participates in the Antitumor Effects of TAT-Cx43266-283 in Glioblastoma Stem Cells. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503072 | PubMed |
| 8 | 11,114,744 | Role of Src expression and activation in human cancer. | Oncogene | 2000 | https://conductscience.org/library/papers/11114744 | PubMed |
| 9 | 34,932,393 | Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. | J Clin Oncol | 2022 | https://conductscience.org/library/papers/34932393 | PubMed |
| 10 | 37,210,176 | Systemic Treatment for Brain Metastases in NSCLC: A New Chapter. | J Thorac Oncol | 2023 | https://conductscience.org/library/papers/37210176 | PubMed |
| 11 | 24,457,967 | A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype. | Cell Death Dis | 2014 | https://conductscience.org/library/papers/24457967 | PubMed |
| 12 | 38,876,188 | A proteomic approach supports the clinical relevance of TAT-Cx43266-283 in glioblastoma. | Transl Res | 2024 | https://conductscience.org/library/papers/38876188 | PubMed |
| 13 | 27,391,443 | Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes. | Oncotarget | 2016 | https://conductscience.org/library/papers/27391443 | PubMed |
| 14 | 40,595,567 | Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates cognitive deficits in a mouse model of amyloidosis. | Nat Commun | 2025 | https://conductscience.org/library/papers/40595567 | PubMed |
| 15 | 29,440,631 | Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29440631 | PubMed |
| 16 | 21,468,047 | Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. | Br J Cancer | 2011 | https://conductscience.org/library/papers/21468047 | PubMed |
| 17 | 29,526,531 | Non-small-cell Lung Cancer With Brain Metastasis at Presentation. | Clin Lung Cancer | 2018 | https://conductscience.org/library/papers/29526531 | PubMed |
| 18 | 31,883,012 | Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo. | Neuro Oncol | 2020 | https://conductscience.org/library/papers/31883012 | PubMed |
| 19 | 17,913,584 | TAT transduction: the molecular mechanism and therapeutic prospects. | Trends Mol Med | 2007 | https://conductscience.org/library/papers/17913584 | PubMed |
| 20 | 18,388,349 | Src as a potential therapeutic target in non-small-cell lung cancer. | Ann Oncol | 2008 | https://conductscience.org/library/papers/18388349 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,667,630 | Advanced Materials for Biologics Delivery to Brain Tumors. | Adv Mater | 2026 | https://conductscience.org/library/papers/42667630 |
Source PubMed
Genes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41756757
GET https://conductscience.org/api/papers/v1/41756757/references?page=2